Evidence map›Paper›PMID 27610422›Full record

ArticleKidney international reports2016

Michael D Hughson, Wendy E Hoy, Susan A Mott, Victor G Puelles, John F Bertram, Cheryl L Winkler, Jeffrey B Kopp

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Treatment of Podocytopathies: Risky Business and Our Personal Journey.Journal of the American Society of Nephrology : JASN · 2024
    Article
  3. The metabolic effects of APOL1 in humans.Pflugers Archiv : European journal of physiology · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Association ofJournal of the American Heart Association · 2020
    Article
  8. Article
  9. Review
  10. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2018
    Review
  11. Circulation. Genomic and precision medicine · 2018
    Article
  12. Kidney international reports · 2018
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Michael D HughsonDepartment of Pathology, University of Mississippi Medical Center, Jackson, Mississippi.
Wendy E HoyCentre for Chronic Disease, The University of Queensland, Brisbane, Queensland, Australia.
Susan A MottCentre for Chronic Disease, The University of Queensland, Brisbane, Queensland, Australia.
Victor G PuellesCardiovascular Program Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, School of Biomedical Sciences, Monash University, Melbourne, Victoria, Australia.
John F BertramCardiovascular Program Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, School of Biomedical Sciences, Monash University, Melbourne, Victoria, Australia.
Cheryl L WinklerBasic Research Laboratory, Center for Cancer Research, National Cancer Institute, Lidos Biomedical Inc., Frederick National Laboratory, Frederick, Maryland.
Jeffrey B KoppKidney Disease Section, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland.
Monash University · AUUniversity of Queensland · AUJackson Memorial Hospital · USNational Cancer Institute · USNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Focal Segmental Glomerulosclerosis: Genetics & MechanismsZIADK043308 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KOPP, JEFFREY BURNETT · 2009 to 2024
$15.7M
Genetics of Renal Disease in African AmericansZIABC010022 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WINKLER, CHERYL · 2009 to 2022
$8.9M
FOCAL SEGMENTAL GLOMERULOSCLEROSIS--PATHOGENESIS AND TREATMENTZ01DK043308 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KOPP, JEFFREY BURNETT · 1997 to 2008
$1.0M
Nephron Count, Birth Weight &Hypertensive Renal DiseaseR01DK065970 · NIDDK · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI HUGHSON, MICHAEL DONALD · 2004 to 2006
$659k
Intramural NIH HHS Z01 DK043308NIDDK NIH HHS R01 DK065970
6 · The paper itself

Abstract

The increased risk of end-stage kidney disease (ESKD) among hypertensive African Americans is partly related to

Identifiers

PMID27610422
PMCPMC5012291
OpenAlexW2339420415

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.